Circulation

MARCH 19, 2025

Circulation, Ahead of Print. The field of cardio-oncology has expanded over the past 2 decades to address the ever-increasing issues related to cardiovascular disease in patients with cancer and survivors.

Cancer 55

Cancer Cardio Oncology Cardiovascular Disease Pediatrics 55

Circulation: Genomic and Precision Medicine

FEBRUARY 24, 2025

Circulation: Genomic and Precision Medicine, Ahead of Print. Artificial intelligence is poised to transform cardio-oncology by enabling personalized care for patients with cancer, who are at a heightened risk of cardiovascular disease due to both the disease and its treatments.

Cardio Oncology 40

Cardio Oncology Cancer Biomarkers Cardiovascular Disease 40

Circulation: Cardiovascular Imaging

JANUARY 8, 2025

Circulation: Cardiovascular Imaging, Ahead of Print. As the field of cardio-oncology continues to expand rapidly, guidance on the management of such toxicities and the development of imaging technologies is crucial.

Cardio Oncology 40

Cardio Oncology Atherosclerosis Cardiomyopathy Cancer 40

Circulation

AUGUST 11, 2024

Circulation, Volume 150, Issue 7 , Page 513-515, August 13, 2024.

Cardio Oncology 45

Cardio Oncology Circulation 45

Circulation: Cardiovascular Quality & Outcomes

JANUARY 8, 2025

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print.

Cardio Oncology 40

Cardio Oncology Circulation Outcomes 40

Cardiology Update

APRIL 9, 2024

The Impella CP is a catheter-based, axial flow pump that pumps blood directly from the left ventricle into the circulation. The DanShock 6 trial ( NCT01633502 ) evaluated the ability of the Impella CP ventricular assist device to decrease death following MI. It is able to deliver 3.5L/min min (approximately 75% of a normal cardiac output).

Angina 52

Angina Myocardial Infarction Aortic valve Coronary Artery Disease 52